##  [What Is the UAE's Medicinal Product Regulatory Framework?](/index%2Ephp/blog/what-is-the-uaes-medicinal-product-regulatory-framework) 

    December 10, 2025 

  ![What Is the Medicinal Product Regulatory Framework in the UAE? A Guide for Regulatory Affairs Professionals ]()

2 min read 

- [Medicinal Products](/index%2Ephp/blog-main-categories/medicinal-products)
- [Regulatory Affairs](/index%2Ephp/blog-main-categories/regulatory-affairs)





 

## Introduction

The **United Arab Emirates (UAE)** has emerged as one of the fastest-growing pharmaceutical markets in the Middle East. With the establishment of the **Emirates Drug Establishment (EDE)** as the national Regulatory authority overseeing medicinal product registration, licensing, and pharmacovigilance, understanding the Regulatory landscape has become crucial for manufacturers and Regulatory professionals seeking market entry.

This guide provides a **step-by-step overview of the medicinal product registration process in the UAE**, helping Regulatory professionals streamline submissions and ensure compliance with **EDE’s evolving requirements**.

## 1. Regulatory Architecture & Pathways under EDE

The **Emirates Drug Establishment (EDE)** regulates the entire lifecycle of medicinal products in the UAE from clinical trial authorization to post-market surveillance.

Key Regulatory aspects include:

- **Marketing Authorization (MA) & Product Registration:** All pharmaceutical products must be registered with EDE before being marketed or imported into the UAE.
- **Dossier Submission (CTD/eCTD):** EDE requires submission in **Common Technical Document (CTD)** or **electronic CTD (eCTD)** format, ensuring alignment with international ICH standards.
- **Pharmacovigilance (PV) Requirements:** Companies must establish a local PV system, appoint a Qualified Person for Pharmacovigilance (QPPV), and ensure timely reporting of adverse drug reactions.
- **MAH & Manufacturing Site Registration:** Manufacturing sites must hold valid GMP certificates issued or recognized by EDE.

## 2. Step-by-Step Guide: How to Register a Medicinal Product in the UAE

**Step 1 – Pre-Submission Planning**

- Determine the **product classification** (new chemical entity, generic, biologic, vaccine, etc.).
- Appoint a **local Marketing Authorization Holder (MAH)** or authorized local agent registered with EDE.
- Verify that manufacturing and import facilities comply with **EDE licensing standards**.

**Step 2 – Dossier Preparation (CTD/eCTD)**

- **Module 1:** UAE-specific administrative and legal information, GMP certificates, Free Sale Certificate (FSC), CPP, and labeling templates.
- **Modules 2–5:** Quality (CMC), non-clinical, and clinical documentation aligned with EDE guidelines and ICH requirements.
- Ensure the dossier is bilingual (Arabic and English) and formatted for eCTD submission.

**Step 3 – Submission & Review Process**

- Submit the dossier through the **EDE digital portal** along with applicable review fees.
- Monitor the application status and respond promptly to EDE queries.
- Follow up for the Product Stability approval, Pricing approval
- Submitting the Samples for Lab Analysis with its related Reference standards and columns.
- Final Certificate approval

**Step 4 – Post-Approval Compliance & Lifecycle Management**

- Maintain valid marketing authorization through timely **renewals** and **variation of submissions**.
- Establish a **pharmacovigilance system** and submit **Periodic Safety Update Reports (PSURs)** as required.
- Ensure **labeling, promotional materials, and advertising** meet EDE regulations (Arabic/English compliance, no misleading claims).and should be approved from EDE before distributing to the market.

## 3. Key Challenges for Regulatory Affairs Professionals in the UAE

- **Adapting to evolving EDE frameworks:** The Emirates Drug Establishment continues to refine and digitize its registration systems.
- **Transition to eCTD submissions:** Companies must invest in compliant eCTD platforms and data integrity validation.
- **Arabic labeling and localization:** Ensuring accurate bilingual labeling remains a top compliance challenge.
- **Regulatory harmonization:** Aligning EDE requirements with GCC and ICH standards for faster approval.

1. **Emerging Trends in UAE Regulatory Affairs**

- Full digital transformation of **drug registration and lifecycle management** through EDE’s online portal.
- Increased focus on **innovative drugs, biologics, and rare disease therapies**.
- Greater reliance on **real-world evidence (RWE)** and **pharmacovigilance data** to support post-approval decisions.
- UAE’s growing position as a **regional pharmaceutical hub** for MENA, offering expedited market access pathways.

Looking to register your medicinal products with the **Emirates Drug Establishment (EDE)**?

**Partner with Freyr’s UAE Regulatory experts** for end-to-end support from CTD/eCTD dossier preparation to post-approval compliance and lifecycle management.

Also, you can add the different product category we can support our client with (Cosmetics, consumer, Medical devices , Software medical devices )

[Contact our team here to](javascript:void(0)) accelerate your UAE market entry.